BLCO
USDBausch + Lomb Corporation Common Shares
वास्तविक समय मूल्य
मूल्य चार्ट
मुख्य मीट्रिक्स
बाजार मीट्रिक्स
खुलना
$12.400
उच्च
$12.488
कम
$12.240
मात्रा
0.40M
कंपनी के मौलिक सिद्धांत
बाजार पूंजीकरण
4.4B
उद्योग
Medical Instruments & Supplies
देश
Canada
ट्रेडिंग आँकड़े
औसत मात्रा
0.85M
एक्सचेंज
NYQ
मुद्रा
USD
52-सप्ताह रेंज
संबंधित समाचार
BLCO Investors Have Opportunity to Join Bausch + Lomb Corporation Fraud Investigation with the Schall Law Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Bausch + Lomb ...
Bausch + Lomb Announces Launch of Senior Secured Notes Offering and Refinancing of Credit Agreement
Bausch + Lomb Corporation (NYSE/TSX:BLCO) ("Bausch + Lomb" or the "company"), a leading global eye health company dedicated to helping people see better to live better, today announced that its subsidiaries, Bausch+Lomb
Barclays Maintains Equal-Weight on Bausch & Lomb, Lowers Price Target to $16
Barclays analyst Matt Miksic maintains Bausch & Lomb with a Equal-Weight and lowers the price target from $19 to $16.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bausch + Lomb Corporation - BLCO
Pomerantz LLP is investigating claims on behalf of investors of Bausch + Lomb Corporation ("Bausch + Lomb" or the "Company") (NYSE: BLCO). Such...
Innovations in Imaging, such as AI-Enhanced Retinal & Fundus Camera Systems are Booming Along with Revenue Opportunities
PALM BEACH, Fla., June 04, 2025 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - The Retinal and Fundis Camera market has shown growth in the recent years and is expected to continue for years to come. Fundus
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bausch + Lomb Corporation - BLCO
Pomerantz LLP is investigating claims on behalf of investors of Bausch + Lomb Corporation ("Bausch + Lomb" or the "Company") (NYSE: BLCO). Such...
Bausch + Lomb to Participate in the 2025 Jefferies Global Healthcare Conference
Bausch + Lomb Corporation (NYSE/TSX:BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that Chief Financial Officer Sam Eldessouky is scheduled to
संबंधित स्टॉक
अपडेट रहें
मूल्य अलर्ट सेट करें, AI विश्लेषण अपडेट और वास्तविक समय बाजार समाचार प्राप्त करें।